Literature DB >> 21707690

A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations.

Airani Sathananthan1, Chiara Dalla Man, Alan R Zinsmeister, Michael Camilleri, Richard J Rodeheffer, Gianna Toffolo, Claudio Cobelli, Robert A Rizza, Adrian Vella.   

Abstract

AIMS/HYPOTHESIS: Individuals with impaired fasting glucose (IFG) are at increased risk of developing diabetes over the subsequent decade. However, there is uncertainty as to the mechanisms contributing to the development of diabetes. We sought to quantitate insulin secretion and action across the prediabetic range of fasting glucose.
METHODS: We studied a cohort of 173 individuals with a fasting glucose concentration <7·0 mM after an overnight fast using a 75-g oral glucose tolerance test (OGTT). Insulin action (S(i)) was estimated using the oral glucose minimal model, and β-cell responsivity indices (φ) were estimated using the oral C-peptide minimal model. The disposition index (DI) for each individual was calculated. The relationship of DI, φ and S(i) with fasting and postchallenge glucose, as well as other covariates, was explored using a generalized linear regression model.
RESULTS: In this cross-sectional study, S(i) and DI were inversely related to fasting glucose concentrations. On the other hand, φ was unrelated to fasting glucose concentrations. S(i), φ and DI were all inversely related to area above basal glucose concentrations after glucose challenge. Multiple parameters including body composition and gender contributed to the variability of S(i) and DI at a given fasting or postchallenge glucose concentration. CONCLUSIONS/
INTERPRETATION: Defects in insulin secretion and action interact with body composition and gender to influence postchallenge glucose concentrations. There is considerable heterogeneity of insulin secretion and action for a given fasting glucose likely because of patient subsets with isolated IFG and normal glucose tolerance.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21707690      PMCID: PMC3983528          DOI: 10.1111/j.1365-2265.2011.04159.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  37 in total

Review 1.  First-phase insulin secretion: does it exist in real life? Considerations on shape and function.

Authors:  Andrea Caumo; Livio Luzi
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09       Impact factor: 4.310

2.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals.

Authors:  Chiara Dalla Man; Marco Campioni; Kenneth S Polonsky; Rita Basu; Robert A Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

3.  Relationship between beta-cell mass and fasting blood glucose concentration in humans.

Authors:  Robert A Ritzel; Alexandra E Butler; Robert A Rizza; Johannes D Veldhuis; Peter C Butler
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

4.  Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.

Authors:  Gerlies Bock; Chiara Dalla Man; Marco Campioni; Elizabeth Chittilapilly; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert Rizza
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 5.  Genetics of type 2 diabetes.

Authors:  Galina Smushkin; Adrian Vella
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

6.  Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Authors:  Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

7.  The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes.

Authors:  J R Levy; J M Olefsky
Journal:  Endocrinology       Date:  1987-12       Impact factor: 4.736

8.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Authors:  Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

9.  Quantitative study of insulin secretion and clearance in normal and obese subjects.

Authors:  K S Polonsky; B D Given; L Hirsch; E T Shapiro; H Tillil; C Beebe; J A Galloway; B H Frank; T Karrison; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

10.  Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels.

Authors:  R Rossell; R Gomis; R Casamitjana; R Segura; E Vilardell; F Rivera
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

View more
  24 in total

1.  Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.

Authors:  Sudha S Shankar; Adrian Vella; Ralph H Raymond; Myrlene A Staten; Roberto A Calle; Richard N Bergman; Charlie Cao; Danny Chen; Claudio Cobelli; Chiara Dalla Man; Mark Deeg; Jennifer Q Dong; Douglas S Lee; David Polidori; R Paul Robertson; Hartmut Ruetten; Darko Stefanovski; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Diabetes Care       Date:  2016-07-12       Impact factor: 19.112

Review 2.  β-cell function after weight-loss induced by bariatric surgery.

Authors:  Adrian Vella
Journal:  Physiology (Bethesda)       Date:  2014-03

3.  Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.

Authors:  Ron T Varghese; Chiara Dalla Man; Anu Sharma; Ivan Viegas; Cristina Barosa; Catia Marques; Meera Shah; John M Miles; Robert A Rizza; John G Jones; Claudio Cobelli; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

4.  Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans.

Authors:  Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; James C Andrews; Robert A Rizza; Aleksey Matveyenko; Giuseppe De Nicolao; Claudio Cobelli; Adrian Vella
Journal:  JCI Insight       Date:  2020-04-09

5.  Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans.

Authors:  Anu Sharma; Ron T Varghese; Meera Shah; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Kent R Bailey; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

6.  Osteocalcin and the Regulation of Glucose Metabolism.

Authors:  Adrian Vella; Rajiv Kumar
Journal:  Clin Rev Bone Miner Metab       Date:  2013-03

7.  Glucose metabolism during rotational shift-work in healthcare workers.

Authors:  Anu Sharma; Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; Claudio Cobelli; Robert A Rizza; Aleksey Matveyenko; Adrian Vella
Journal:  Diabetologia       Date:  2017-05-27       Impact factor: 10.122

8.  Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance.

Authors:  Ron T Varghese; Chiara Dalla Man; Marcello C Laurenti; Francesca Piccinini; Anu Sharma; Meera Shah; Kent R Bailey; Robert A Rizza; Claudio Cobelli; Adrian Vella
Journal:  Diabetes Obes Metab       Date:  2017-09-27       Impact factor: 6.577

9.  TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes.

Authors:  Meera Shah; Ron T Varghese; John M Miles; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Kent R Bailey; Robert A Rizza; Adrian Vella
Journal:  Diabetes       Date:  2015-11-02       Impact factor: 9.461

Review 10.  What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?

Authors:  J D Adams; Adrian Vella
Journal:  Metab Syndr Relat Disord       Date:  2018-07-11       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.